Trial Profile
Exploratory study of paliperidone in patients with schizophrenia to investigate the safety and efficacy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Feb 2011
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Adverse reactions
- Sponsors Janssen Pharmaceutical KK
- 20 Oct 2006 New trial record.